骨髓Coombs试验阳性血细胞减少症患者调节性T细胞数量及功能状态  被引量:11

Quantity and function of regulatory T cells in hemocytopenic patients with positive BMMNC-Coombs test

在线阅读下载全文

作  者:付蓉[1] 陈瑾[1] 王红蕾[1] 王珺[1] 李丽娟[1] 刘惠[1] 王一浩[1] 任悦[1] 邵宗鸿[1] 

机构地区:[1]天津医科大学总医院血液科,300052

出  处:《中华医学杂志》2010年第42期2989-2993,共5页National Medical Journal of China

基  金:基金项目:国家“十一五”科技支撑项目(2008BAl61BOO);国家自然科学基金(30670886、30470749、30971285、30971286);天津市科技支撑计划重点项目(07ZCGYSF00600);天津市卫生局科技基金项目(03KZ26);天津市应用基础及前沿技术研究计划(08JcYBJc07800);天津市高等学校科研基金(200317)

摘  要:目的 观察骨髓单个核细胞(BMMNC)Coombs试验阳性血细胞减少症(即免疫相关性血细胞减少症,IRP)患者骨髓调节性T(Treg)细胞数量及功能状态,探讨Treg细胞在IRP免疫发病中的作用.方法 选取2008年9月至2009年3月天津医科大学总医院血液科住院的初治IRP患者30例、经治疗达缓解或基本治愈(恢复期)IRP患者36例及健康对照24例.采用酶联免疫吸附试验(ELISA)法测定骨髓上清白细胞介素(IL)2、转化生长因子(TGF)β水平 采用流式细胞术(FCM)检测骨髓Treg细胞数量(CD4+CD25+/CD4+)、Treg细胞激活状态(CD4+CD25+CD127low/CD4+) 反转录-聚合酶链反应(RT-PCR)技术测定BMMNC中Treg细胞转录因子Foxp3、半乳糖凝集素10(galectin-10)mRNA的表达.结果 IRP初治组、恢复组骨髓IL-2[(5.6±1.7)、(6.2±2.5)μg/L]、TGF-β[(1.8±0.7)、(1.9±0.8)μg/L]均显著低于健康对照组[IL-2:(7.9±3.7)μg/L,TGF-β:(2.5±0.9)μg/L,均P〈0.05] 初治组骨髓CD4+CD25+/CD4+(22.5%±9.5%)低于恢复组和健康对照组(27.1%±7.1%、30.6%±8.6%,均P〈0.05) 初治组骨髓CD4+CD25+CD127low/CD4+(7.2%±2.7%)明显低于恢复组和健康对照组(9.1%±4.7%、10.4%±3.2%,均P〈0.05).初治组BMMNC Foxp3 mRNA相对表达量(0.34±0.25)低于恢复组和健康对照组(0.69±0.51、0.82±0.66,P〈0.05),galectin-10 mRNA相对表达量(0.66±0.11)低于恢复组和正常对组(0.74±0.11、0.76±0.09,均P〈0.05).结论 IRP患者Treg细胞数量和功能异常可能在IRP免疫发病机制中发挥重要作用.Objective To investigate the quantity and function of regulatory T cells in immunorelated pancytopenia (IRP)and explore the significance of Treg cells in the pathogenesis of IRP. Methods Sixty-six IRP patients and 24 healthy donors were enrolled. The levels of IL-2 and TGF-β were detected by ElISA. The ratios of CD4+ CD25 +/CD4+ and CD4+ CD25+ CD127low/CD4+ in bone marrow were examined with flow cytometry. The expressions of Foxp3 and galectin-10 mRNA in BMMNC were measured by semi-quantitative RT-PCR. Results The levels of IL-2 and TGF-β in bone marrow of untreated or recovered IRP patients[(5.6±1.7) 、(6.2±2.5) μg/L,(1.8±0.7)、(1.9±0.8)μg/L]were significantly lower than those of healthy controls [(7.9±3.7)、(2.5±0.9)μg/L, all P〈 0.05]. The ratio of CD4 + CD25 +/CD4+ cells in bone marrow of untreated IRP patients (22.5%±9.5%) was significantly lower than that of recovered IRP patients or healthy controls (27.1% ±7.1% 、30.6%±8.6% ,both P〈0.05). The ratio of CD4+ CD25 + CD127low/CD4 + cells in bone marrow of untreated IRP patients was significantly lower than that of recovered IRP patients or healthy controls (7.2%±2.7% vs 9.1%±4.7% 、10.4%±3.2% ,both P 〈0.05). The relative mRNA expressions of Foxp3 and galectin-10 were 0.34 ±0.25, 0.69±0.51, 0.82±0.66 and 0.66±0.11, 0.74±0.11,0.76±0.09 in three groups respectively. The expressions of two factors in untreated IRP patients were significantly lower than those in recovered IRP patients or normal controls (all P 〈 0.05). Conclusion The abnormalities in quantity and function of Treg cells in IRP patients might play an important role in the pathogenesis of IRP.

关 键 词:全血细胞减少 COOMBS试验 免疫性疾病 T淋巴细胞 调节性 

分 类 号:R686[医药卫生—骨科学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象